embedded image;wherein R1 is selected from alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl, and heterocycloalkyl; R2 is selected from alkyl, alkenyl, alkyny, heteroalkyl, haloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl; R3 is selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl; W is selected from Ch2, O and S; n is 0 to about 3: X is selected from S or O; Y, if present, is selected from a bond, aryl, NH, NR, O or S, where R3 is selected from hydrogen, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl; and Z, if present, can represent a bond or is selected from lower alkyl, O or S are disclosed. Also disclosed are uses of such compounds for treating a variety of disease conditions, including cancer."/> Agents for regulation of colon cancer gene expression
首页> 外国专利> Agents for regulation of colon cancer gene expression

Agents for regulation of colon cancer gene expression

机译:调节结肠癌基因表达的药物

摘要

Compounds of the general structure according to Formula (I) embedded image;wherein R1 is selected from alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl, and heterocycloalkyl; R2 is selected from alkyl, alkenyl, alkyny, heteroalkyl, haloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl; R3 is selected from aryl, heteroaryl, cycloalkyl, and heterocycloalkyl; W is selected from Ch2, O and S; n is 0 to about 3: X is selected from S or O; Y, if present, is selected from a bond, aryl, NH, NR, O or S, where R3 is selected from hydrogen, alkyl, alkenyl, alkynyl, heteroalkyl, haloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkylalkyl; and Z, if present, can represent a bond or is selected from lower alkyl, O or S are disclosed. Also disclosed are uses of such compounds for treating a variety of disease conditions, including cancer.
机译:具有通式(I)的一般结构的化合物<化学id =“ CHEM-US-00001”> <图像alt =“嵌入式图像” file =“ US06548539-20030415-C00001.GIF” he =“ 60.24375” id =“ EMI-C00001“ imgContent =” undefined“ imgFormat =” GIF“ wi =” 166.10265“ /> ;其中R 1 选自烷基,烯基,炔基,杂烷基,卤代烷基,芳基,芳基烷基,杂芳基,杂芳基烷基,环烷基和杂环烷基; R Sup 2选自烷基,烯基,炔基,杂烷基,卤代烷基,芳基烷基,杂芳基烷基,环烷基烷基和杂环烷基烷基; R 3 选自芳基,杂芳基,环烷基和杂环烷基; W选自Ch 2 ,O和S; n为0至约3:X选自S或O;如果存在的话,Y选自键,芳基,NH,NR,O或S,其中R 3选自氢,烷基,烯基,炔基,杂烷基,卤代烷基,芳基烷基,杂芳基烷基,环烷基烷基和杂环烷基烷基;如果存在,则Z和Z可以表示一个键或选自低级烷基,公开了O或S。还公开了此类化合物在治疗包括癌症在内的多种疾病中的用途。

著录项

  • 公开/公告号US6548539B1

    专利类型

  • 公开/公告日2003-04-15

    原文格式PDF

  • 申请/专利权人 AVALON PHARMACEUTICALS;

    申请/专利号US20020090866

  • 申请日2002-03-05

  • 分类号A61K313/40;A61K311/70;A61K311/65;C07D3010/20;C07C2730/00;

  • 国家 US

  • 入库时间 2022-08-22 00:07:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号